Remove 2019 Remove Clinical Pharmacology Remove Communication
article thumbnail

Why R&D innovation holds the key to greater patient impact

European Pharmaceutical Review

In 2019, the pharmaceutical industry spent $83 billion on R&D, which is about 10 times what the industry spent per year in the 1980s, 4 yet the average duration to develop a new medicine is still around 10-15 years. About the authors Dr Nils Eckardt joined BeiGene in February 2019 as Vice President, Medical Affairs, Europe.

article thumbnail

NHC Comments on Landmark FDA Guidance for Diversity in Clinical Trials

Putting Patients First Blog

This includes being aware of historical injustices that may have contributed to mistrust in the medical system and understanding the unique needs and concerns of different communities. Effective communication with diverse populations is essential for ensuring that all individuals can participate in clinical trials. Williams, S.,